The Asurys system is the latest addition to Boston Scientific’s StoneSmart Solutions product ecosystem.
Boston Scientific Corporation (NYSE:BSX) is one of the 10 Best Growth Stocks to Buy for the Next Decade. Boston Scientific ...
The Asurys Fluid Management System is designed to be used with an endoscope to provide irrigation and distention during kidney stone, BPH, and other procedures.
New technology designed to provide a single irrigation management system for ureteroscopy, cystoscopy, percutaneous nephrolithotomy (PCNL) and benign prostatic hyperplasia ...
MARLBOROUGH, Mass. - Boston Scientific Corporation (NYSE:BSX) announced today it received U.S. Food and Drug Administration 510(k) clearance for the Asurys Fluid Management System, according to a ...
Boston Scientific (NYSE:BSX) announced today that it received FDA 510(k) clearance for its Asurys fluid management system.
The system can be used as an irrigation option for ureteroscopy, cystoscopy, percutaneous nephrolithotomy, and benign prostatic hyperplasia procedures. The FDA has granted 510(k) clearance to the ...
To evaluate the safety and clinical performance of a fluid-management system with intrarenal pressure management during flexible ureteroscopy in patients with renal or ureteral stones. prospective, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results